78 related articles for article (PubMed ID: 15130315)
21. The Effect of Docetaxel-Loaded Micro-Bubbles Combined with Low-Frequency Ultrasound in H22 Hepatocellular Carcinoma-Bearing Mice.
Ren ST; Shen S; He XY; Liao YR; Sun PF; Wang B; Zhao WB; Han SP; Wang YL; Tian T
Ultrasound Med Biol; 2016 Feb; 42(2):549-60. PubMed ID: 26651601
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
Zhu F; Jiang Y; Luo F; Li P
J Drug Target; 2015 May; 23(4):323-34. PubMed ID: 25609362
[TBL] [Abstract][Full Text] [Related]
23. [Study on the inhibitory effect of small tripeptide CMS024 on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis].
Li Y; Tang ZY; Wang L; Yao Z; Lu R; Xue Q; Gao DM; Chen J
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):675-9. PubMed ID: 15130313
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa).
Bianco C; Tortora G; Bianco R; Caputo R; Veneziani BM; Caputo R; Damiano V; Troiani T; Fontanini G; Raben D; Pepe S; Bianco AR; Ciardiello F
Clin Cancer Res; 2002 Oct; 8(10):3250-8. PubMed ID: 12374696
[TBL] [Abstract][Full Text] [Related]
25. Effect of luteolin on gene expression in mouse H22 hepatoma cells.
Niu JX; Guo HP; Gan HM; Bao LD; Ren JJ
Genet Mol Res; 2015 Nov; 14(4):14448-56. PubMed ID: 26600503
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma.
Leung TW; Yu S; Johnson PJ; Geschwind J; Vogl TJ; Engelmann K; Gores GJ; Giovannini M; O'Grady J; Heneghan M; Stewart M; Orenberg EK; Thuluvath PJ
J Clin Oncol; 2003 Feb; 21(4):652-8. PubMed ID: 12586802
[TBL] [Abstract][Full Text] [Related]
27. Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).
Inoue H; Miyazono N; Hori A; Miyake S; Satake M; Kanetsuki I; Nishida H; Ikeda K; Nakajo M
Acta Radiol; 1993 Jul; 34(4):388-91. PubMed ID: 8391290
[TBL] [Abstract][Full Text] [Related]
28. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
Yamashita T; Arai K; Sunagozaka H; Ueda T; Terashima T; Yamashita T; Mizukoshi E; Sakai A; Nakamoto Y; Honda M; Kaneko S
Oncology; 2011; 81(5-6):281-90. PubMed ID: 22133996
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer.
Shintani S; Li C; Mihara M; Terakado N; Yano J; Nakashiro K; Hamakawa H
Int J Cancer; 2003 Dec; 107(6):1030-7. PubMed ID: 14601066
[TBL] [Abstract][Full Text] [Related]
30. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
[TBL] [Abstract][Full Text] [Related]
31. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
32. G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.
Li L; Khan MN; Li Q; Chen X; Wei J; Wang B; Cheng JW; Gordon JR; Li F
Oncol Rep; 2015 Feb; 33(2):751-7. PubMed ID: 25504010
[TBL] [Abstract][Full Text] [Related]
33. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
34. Anti-hepatoma activity and mechanism of corn silk polysaccharides in H22 tumor-bearing mice.
Yang J; Li X; Xue Y; Wang N; Liu W
Int J Biol Macromol; 2014 Mar; 64():276-80. PubMed ID: 24315949
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Okamura M; Shimada J; Sakagami H
Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853
[TBL] [Abstract][Full Text] [Related]
36. [Effects of Shiquanyuzhentang on immunologic function of H
Zhu YC; Zhan GJ; Yuan DP; Yang FM; Huang Q
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jan; 33(1):51-55. PubMed ID: 29926607
[TBL] [Abstract][Full Text] [Related]
37. [Experimental studies on anti-mouse hepatocellular carcinoma effects of cisplatin combined with exosomes].
Wang SH; Shen Y; Li J; Xiang ZW; Fan WK; Chen L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jan; 25(1):49-52. PubMed ID: 19126388
[TBL] [Abstract][Full Text] [Related]
38. Effect of sodium thiosulphate and cis-diamminedichloroplatinum on FADU tumour cells in nude mice.
Viallet NR; Blakley BW; Begleiter A; Leith MK
J Otolaryngol; 2005 Dec; 34(6):371-3. PubMed ID: 16343395
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effectiveness and toxicity of cisplatin-loaded long-circulating and pH-sensitive liposomes against Ehrlich ascitic tumor.
de Carvalho Maroni L; de Oliveira Silveira AC; Leite EA; Melo MM; de Carvalho Ribeiro AF; Cassali GD; de Souza CM; Souza-Fagundes EM; Caldas IR; Araújo MS; Martins-Filho OA; de Oliveira MC; Teixeira-Carvalho A
Exp Biol Med (Maywood); 2012 Aug; 237(8):973-84. PubMed ID: 22903135
[TBL] [Abstract][Full Text] [Related]
40. Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).
Elkind NB; Szentpétery Z; Apáti A; Ozvegy-Laczka C; Várady G; Ujhelly O; Szabó K; Homolya L; Váradi A; Buday L; Kéri G; Német K; Sarkadi B
Cancer Res; 2005 Mar; 65(5):1770-7. PubMed ID: 15753373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
